Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0376358 (
prostate cancer
)
59,338
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous studies showed that
HCRP1
is decreased in tumor cells compared with normal tissue, and functions as a tumor suppressor. However, its expression pattern and function in human
prostate cancer
remain unclear. In this study we examined
HCRP1
expression in
prostate cancer
cell lines via western blotting. Thereafter, we performed CCK-8 assay and matrigel invasion assay after cells were transfected with
HCRP1
overexpression plasmid or siRNA. We further investigated the possible mechanism involved in
HCRP1
's regulation to
prostate cancer
cell proliferation and invasion. We found that
HCRP1
negatively regulates EGFR activity and expression of its downstream proteins. Moreover, we found that
HCRP1
is negatively correlated with multi-drug resistant related proteins after cells were treated with paclitaxel, cisplatin or gefitinib, indicating its inhibiting effect of chemotherapy resistance. In summary, our results provided evidence that
HCRP1
is a negative regulator in
prostate cancer
progression, metastasis and multi-drug resistance.
...
PMID:HCRP1 regulates proliferation, invasion, and drug resistance via EGFR signaling in prostate cancer. 2845 58